FOLFOX + ziv-aflibercept adding anti-angiogenic agent to chemotherapy in advanced gastric adenocarcinoma ASCO GI 2016

Daniel Catenacci, MD of The University of Chicago Medicine discusses FOLFOX + ziv-aflibercept adding anti-angiogenic agent to chemotherapy in advanced gastric adenocarcinoma at ASCO GI 2016 Author: ASCOGI2016 Added: 01/26/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts